\
&
Contact us
\
&
Contact us
NCP Flanders has extended the duration of its short satisfaction survey to gather valuable feedback and suggestions on the NCP services. The survey is fully anonymous and is open until 9 October 2026. It is organised into three sections: NCP Flanders assistance, info sessions, and NCP Flanders website & LinkedIn. If you are not familiar with one of these sections, the survey will automatically guide you to the next section. The NCP Flanders team would greatly appreciate it if you could take a few minutes to fill in the survey and provide your opinion via this link. If you would like to get in touch with NCP Flanders, please email info@ncpflanders.be
The pre-announcement outlines support for pragmatic, phase III, randomised controlled, multinational interventional investigator-initiated clinical studies. Eligible studies are expected to focus on either comparative-effectiveness research or drug repurposing of off-patent medicines. Project duration may be up to 48 months.For Belgium, the Belgian Health Care Knowledge Centre (KCE) is participating in the upcoming call and is expected to act as Belgian funding organisation in the context of the call. Further information on how to submit to KCE and additional requirements for Belgium is expected to become available after call publication. Interested applicants can review the pre-announcement on the ERA4Health call page. More information will become available after the call publication scheduled for 27 October 2026.Background: The Partnership “Fostering a European Research Area for Health” (ERA4Health) aims to increase European transnational collaborative research funding through joint programming in priority areas that address European public health needs.
The updated version of the Horizon Europe Work Programme (HE WP) 2026-2027 General Annexes was published on 29 September 2026 (available here). This article provides the changes compared to the previous version (1.0 with publication date 11 December 2025, available here), mainly focused on the participation of Chinese entitities. Participation of China The 2025 version of the General Annexes of the Work Programme, explicitly identified the limited areas where Chinese entities remain eligible in Research and Innovation Actions (RIAs). In this updated version, the destination "Transformative change towards a nature-positive economy and society" part of the Bridging Actions of the Horizontal Activities Work Programme has been added to this list. From 4 to 10 critical technology areas on Chinese-controlled entities (p. 15) The scope of the restriction on Chinese-controlled entities in Innovation Actions has been expanded from 4 to 10 critical technology areas.The December 2025 version referred specifically to four areas: advanced semiconductors; artificial intelligence; quantum technologies; biotechnologies In the updated General Annexes the following six areas have been added to this list: advanced connectivity, navigation and digital technologies; advanced sensing technologies; space and propulsion technologies; energy technologies; robotics and autonomous systems; advanced materials, manufacturing and recycling technologies
PRISM is a Horizon Europe-funded consortium that aims to strengthen multinational paediatric research by offering infrastructure and expertise to investigator-initiated studies. Through this open call, PRISM is seeking to pilot paediatric clinical studies, which will be selected through an independent two-stage evaluation process.Eligible proposals include pragmatic investigator-initiated randomised controlled trials comparing or improving therapeutic, diagnostic or preventive healthcare strategies, as well as prospective observational cohort studies. Studies must be carried out in 3 to 6 countries across the EU, Norway, Switzerland, the United Kingdom and Canada, with a maximum of 15 sites.According to the call page, the maximum study duration is 30 months. Requested budgets may range from €1 million to €2 million for interventional studies, or up to €1 million for observational studies. Information, including the call text and application guidelines, is available on the call page. The deadline for letters of intent (first stage) is 31 December 2026; the deadline for full applications (second stage) is 30 June 2027.Questions can be sent to the PRISM Joint Call Secretariat at call2026@prismeu.org.
Description of the call EIT Health, a Knowledge and Innovation Community of the European Institute of Innovation and Technology (EIT), is looking for a consortium to deliver the "Beyond the Idea: From Concept to Venture" programme in 2027 and 2028. The programme helps master’s and doctoral students validate early-stage healthcare innovations and develop them into business ventures.For two cohorts, the selected consortium is expected to provide masterclasses, mentoring and a final Pitch Day, among other activities. Participants will work on the commercial viability of their solution, a business model and a roadmap for setting up a company. Who can apply? The call is aimed at a consortium comprising one university incubator and one entrepreneurship support provider. Together, they must demonstrate experience in incubation, mentoring, market validation, business development and venture building, as well as a sound understanding of both the academic context and the pathway towards a start-up. Funding and timeline Available funding amounts to a maximum of €36,000 and the application deadline is 2 November 2026. All information about the call is available here. An online Q&A session will take place on 15 October 2026. Register here.
Sign up for personalised information!
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you. By signing up, you can opt in for email notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Miricle project, ‘Mine Risk Clearance for Europe’, obtained funding under the European Defence Industrial Development programme call ‘Underwater control contributing to resilience at sea’. The main objective of the project was to achieve a European and sovereign capacity in future mine warfare and create a path for the next generation ‘made in Europe’ countermeasure solutions. In order to realise this objective, Miricle addressed various stages: studies, design, prototyping and testing. These stages inter alia included the successful testing of an XL Unmanned Underwater Vehicle, a protototyped mine disposal system and multiple innovative systems to detect buried mines. Flanders Marine Institute (VLIZ), was one of the five Belgian partners in the consortium. Within the project, VLIZ was able to forward its research on the acoustic imaging of the seabed to spatially map and visualize buried structures and objects - in this case buried mines - in the highest possible detail. VLIZ also led the work on ‘Port and Offshore Testing’, building on the expertise of the institute in the field of marine operations and technology.
